Galantamine

Details

Top
Internal ID 3fd1a85e-b0ea-4ee3-a34c-eaf4701419bf
Taxonomy Alkaloids and derivatives > Amaryllidaceae alkaloids > Galanthamine-type amaryllidaceae alkaloids
IUPAC Name (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol
SMILES (Canonical) CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O
SMILES (Isomeric) CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O
InChI InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1
InChI Key ASUTZQLVASHGKV-JDFRZJQESA-N
Popularity 2,481 references in papers

Physical and Chemical Properties

Top
Molecular Formula C17H21NO3
Molecular Weight 287.35 g/mol
Exact Mass 287.15214353 g/mol
Topological Polar Surface Area (TPSA) 41.90 Ų
XlogP 1.80
Atomic LogP (AlogP) 1.85
H-Bond Acceptor 4
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
Galantamine
357-70-0
(-)-Galanthamine
Lycoremin
Lycoremine
Galantamin
Reminyl
Jilkon
Galantamina
(-)-Galantamine
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Galantamine

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9949 99.49%
Caco-2 + 0.8469 84.69%
Blood Brain Barrier + 1.0000 100.00%
Human oral bioavailability + 0.7571 75.71%
Subcellular localzation Lysosomes 0.5635 56.35%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9392 93.92%
OATP1B3 inhibitior + 0.9498 94.98%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior - 0.7042 70.42%
P-glycoprotein inhibitior - 0.9165 91.65%
P-glycoprotein substrate + 0.5424 54.24%
CYP3A4 substrate + 0.7588 75.88%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate + 0.7066 70.66%
CYP3A4 inhibition - 0.8832 88.32%
CYP2C9 inhibition - 0.9071 90.71%
CYP2C19 inhibition - 0.8301 83.01%
CYP2D6 inhibition - 0.5414 54.14%
CYP1A2 inhibition - 0.9046 90.46%
CYP2C8 inhibition - 0.8226 82.26%
CYP inhibitory promiscuity - 0.9439 94.39%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.8900 89.00%
Carcinogenicity (trinary) Non-required 0.6110 61.10%
Eye corrosion - 0.9890 98.90%
Eye irritation - 0.9877 98.77%
Skin irritation - 0.8137 81.37%
Skin corrosion - 0.9396 93.96%
Ames mutagenesis - 0.7300 73.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5207 52.07%
Micronuclear - 0.6200 62.00%
Hepatotoxicity - 0.9375 93.75%
skin sensitisation - 0.8050 80.50%
Respiratory toxicity + 0.9667 96.67%
Reproductive toxicity + 0.8444 84.44%
Mitochondrial toxicity + 0.9875 98.75%
Nephrotoxicity - 0.7182 71.82%
Acute Oral Toxicity (c) III 0.4944 49.44%
Estrogen receptor binding - 0.6248 62.48%
Androgen receptor binding - 0.8513 85.13%
Thyroid receptor binding + 0.5953 59.53%
Glucocorticoid receptor binding - 0.6879 68.79%
Aromatase binding - 0.8282 82.82%
PPAR gamma - 0.6077 60.77%
Honey bee toxicity - 0.8501 85.01%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity + 0.5500 55.00%
Fish aquatic toxicity + 0.7513 75.13%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL220 P22303 Acetylcholinesterase 550 nM
2600 nM
350 nM
800 nM
800 nM
300 nM
1000 nM
300 nM
2090 nM
2000 nM
2090 nM
2010 nM
2090 nM
800 nM
1100 nM
2670 nM
700 nM
2000 nM
350 nM
2010 nM
300 nM
500 nM
100 nM
2600 nM
1156 nM
600 nM
980 nM
800 nM
590 nM
800 nM
600 nM
635.33 nM
1180 nM
1070 nM
2010 nM
350 nM
500 nM
530 nM
2100 nM
2010 nM
500 nM
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
PMID: 24606395
PMID: 21189039
PMID: 21216144
PMID: 21459491
PMID: 21459491
PMID: 22425563
PMID: 22775474
PMID: 23199476
PMID: 23454132
PMID: 23540646
PMID: 23570788
PMID: 23984975
PMID: 24461561
PMID: 12166941
PMID: 24704612
PMID: 24934993
PMID: 25189690
PMID: 25537270
PMID: 26159481
PMID: 26735910
PMID: 26841168
DOI: 10.1007/s00044-011-9804-0
DOI: 10.1016/0960-894X(96)00102-3
DOI: 10.1039/C5MD00274E
via CMAUP
PMID: 20575555
PMID: 10869205
PMID: 15715468
PMID: 16483771
PMID: 16570913
PMID: 16945529
PMID: 16945529
PMID: 16989531
PMID: 17822295
PMID: 17850125
PMID: 18479118
PMID: 18650096
PMID: 20954721
PMID: 20025280
PMID: 18954037
PMID: 18681480
CHEMBL3577 P00352 Aldehyde dehydrogenase 1A1 15848.9 nM
Potency
via CMAUP
CHEMBL1914 P06276 Butyrylcholinesterase 8400 nM
10000 nM
7300 nM
18000 nM
18600 nM
8000 nM
7300 nM
7000 nM
7300 nM
8500 nM
15800 nM
12700 nM
8394.6 nM
8000 nM
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
IC50
PMID: 16945529
PMID: 23540646
PMID: 12166941
PMID: 12824041
PMID: 21216144
DOI: 10.1007/s00044-011-9754-6
PMID: 15715468
PMID: 23199476
PMID: 16570913
PMID: 18681480
PMID: 24508831
PMID: 24934993
PMID: 16945529
PMID: 18650096
CHEMBL1293235 P02545 Prelamin-A/C 35481.3 nM
Potency
via CMAUP

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 99.24% 96.09%
CHEMBL3192 Q9BY41 Histone deacetylase 8 92.86% 93.99%
CHEMBL253 P34972 Cannabinoid CB2 receptor 92.81% 97.25%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 91.22% 94.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 90.23% 95.89%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.80% 95.56%
CHEMBL1293249 Q13887 Kruppel-like factor 5 89.70% 86.33%
CHEMBL225 P28335 Serotonin 2c (5-HT2c) receptor 88.62% 89.62%
CHEMBL4895 P30530 Tyrosine-protein kinase receptor UFO 86.38% 90.95%
CHEMBL5469 Q14289 Protein tyrosine kinase 2 beta 83.74% 91.03%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 82.98% 85.14%
CHEMBL4306 P22460 Voltage-gated potassium channel subunit Kv1.5 82.50% 94.03%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.99% 97.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 80.63% 94.45%
CHEMBL1994 P08235 Mineralocorticoid receptor 80.18% 100.00%

Cross-Links

Top
PubChem 9651
NPASS NPC78359
ChEMBL CHEMBL659
LOTUS LTS0038419
wikiData Q412690